These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38500179)

  • 61. Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus.
    Guo F; Tang L; Shu S; Sehgal M; Sheraz M; Liu B; Zhao Q; Cheng J; Zhao X; Zhou T; Chang J; Guo JT
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Saturated Fatty Acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic Fatty liver disease by toll-like receptor 4-mediated innate immune response.
    Zhang RN; Pan Q; Zhang Z; Cao HX; Shen F; Fan JG
    Hepat Mon; 2015 May; 15(5):e27909. PubMed ID: 26045709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Establishment and primary application of a mouse model with hepatitis B virus replication.
    Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H
    World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.
    Yang HY; Zheng NQ; Li DM; Gu L; Peng XM
    Virol J; 2014 Sep; 11():165. PubMed ID: 25224377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.
    Hösel M; Quasdorff M; Ringelhan M; Kashkar H; Debey-Pascher S; Sprinzl MF; Bockmann JH; Arzberger S; Webb D; von Olshausen G; Weber A; Schultze JL; Büning H; Heikenwalder M; Protzer U
    Cell Mol Gastroenterol Hepatol; 2017 Nov; 4(3):339-363. PubMed ID: 28884137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling.
    Lin Y; Wu C; Wang X; Liu S; Zhao K; Kemper T; Yu H; Li M; Zhang J; Chen M; Zhu Y; Chen X; Lu M
    Autophagy; 2020 Mar; 16(3):548-561. PubMed ID: 31204557
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.
    Wang L; Cao M; Wei QL; Zhao ZH; Xiang Q; Wang HJ; Zhang HT; Lai GQ
    PLoS One; 2017; 12(4):e0175992. PubMed ID: 28426720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Establishment and application of hepatitis B virus persistent replication model in IFNAR(-/-) mouse.
    Chen MF; Lin Y; Xia YC; Sun C; Feng XM; Lu MJ; Yang DL; Wu J
    J Huazhong Univ Sci Technolog Med Sci; 2013 Jun; 33(3):392-397. PubMed ID: 23771666
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production.
    Phillips S; Chokshi S; Chatterji U; Riva A; Bobardt M; Williams R; Gallay P; Naoumov NV
    Gastroenterology; 2015 Feb; 148(2):403-14.e7. PubMed ID: 25305505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sulforaphane effectively inhibits HBV by altering Treg/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo.
    Xu R; Wu Y; Xiang X; Lv X; He M; Xu C; Lai G; Xiang T
    Virus Res; 2024 Mar; 341():199316. PubMed ID: 38215982
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B.
    Zheng NQ; Zheng ZH; Xu HX; Huang MX; Peng XM
    Virol J; 2017 Apr; 14(1):77. PubMed ID: 28407787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between hepatitis B virus deoxyribonucleic acid, HBeAg/anti-HBe status in serum and HBcAg in liver: its clinical significance in chronic HBsAg carriers.
    Kiyosawa K; Nakamura M; Sodeyama T; Tanaka E; Nakano Y; Furuta S
    Jpn J Med; 1988 Aug; 27(3):267-71. PubMed ID: 3057267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
    Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
    Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. rt269I Type of Hepatitis B Virus (HBV) Leads to HBV e Antigen Negative Infections and Liver Disease Progression via Mitochondrial Stress Mediated Type I Interferon Production in Chronic Patients With Genotype C Infections.
    Lee SY; Choi YM; Oh SJ; Yang SB; Lee J; Choe WH; Kook YH; Kim BJ
    Front Immunol; 2019; 10():1735. PubMed ID: 31402915
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity.
    Lan T; Wei Z; He Y; Wan S; Liu L; Cheng B; Li R; Chen H; Liu G; Meng Z
    Virol J; 2021 Feb; 18(1):37. PubMed ID: 33602251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Steroid receptor coactivator 3 inhibits hepatitis B virus gene expression through activating Akt signaling to prevent HNF4α nuclear translocation.
    Li M; Wang Y; Xia X; Mo P; Xu J; Yu C; Li W
    Cell Biosci; 2019; 9():64. PubMed ID: 31417670
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of hepatitis B virus replication by activation of the cGAS-STING pathway.
    He J; Hao R; Liu D; Liu X; Wu S; Guo S; Wang Y; Tien P; Guo D
    J Gen Virol; 2016 Dec; 97(12):3368-3378. PubMed ID: 27902332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.